Set within the Pharmaceutical Special Economic Zone (SEZ) in Ahmedabad, India, our discovery facility offers Medicinal Chemistry Support Services such as Custom Synthesis, Analytical Services, DMPK, and Route Scouting. Our business models encompass FTE, Flexi FTE (Route Scouting), and Fixed Price/Fee for Service.

Located in Aurora, Canada, the facility excels in complex NCEs development, GMP manufacturing with 14 reactors (200-2000 L), adeptly handling high-potency APIs (≥ OEL 1 mg/m3) all on a sprawling 10-acre expanse

Experience excellence with our Riverview, US facility, specializing in complex NCEs development, manufacturing high-potency APIs (OELs down to 100 ng/m³), utilizing reactors up to 4,000 L (-10°C to 200°C) across our expansive 10.3-acre site

Situated in Digwal, India, we specialize in API and key intermediates' development and commercial manufacturing. Our 101-acre campus features over 240 reactors with a combined 750 kL capacity, fostering innovation across 3 distinct manufacturing zones

Based in Ennore, India, our facility delivers comprehensive chemistry services encompassing intermediates, RSM synthesis, and early-phase API supply up to phase II, supported by Kilo lab to multi-ton capabilities. Seamlessly back-integrated with all our API manufacturing units

In Mumbai, our R&D facility is a hub of innovation, focused on advancing new products, optimizing costs, and pioneering novel routes for generic APIs. Supported by state-of-the-art analytical research capabilities, we engineer non-infringing API processes

Located in Morpeth, UK, our facility holds 40+ years of expertise in Oral solids and hormonal products development and manufacturing. Proficient in rapid product development, technical transfer, the site has experience of handling compounds with an OEL as low as 0.04 μg/m3

In Sellersville, US, our facility offers 50+ years of experience in commercialization of Oral Solids. We excel in high-potency and controlled substance formulations, offering diverse product development and manufacturing for OSDs, liquids, creams, and ointments. The facility also offers the capability in serialized packaging for OSDs and packaging for liquids, creams, and ointments.

At our Lexington facility in the US, we offer Sterile Compounding, Fill/Finish, and Lyophilization capabilities. Proficient in highly potent drugs, we utilize isolator technology for aseptic environments. Our fully integrated offerings also support ADC Drug manufacture

In Pithampur, India, our facility excels in Clinical, Pre-Exhibit & Exhibit, and Commercial manufacturing for OSDs. With a capacity of 4.5 billion doses, we specialize in diverse dosage forms including Oral solids, capsule fillings, and Form Fill Seals

In Ahmedabad, India, our facility covers development to clinical manufacturing (50 g to 35 kg). We adeptly manage Low RH compounds (30%) and handle high-potency substances (OEL: 1 µg/m3)

Located in Grangemouth, UK, our facility provides a comprehensive suite of end-to-end services for ADC development and manufacturing. With batch sizes up to approximately 4.0kg, the facility can handle compounds with an OEL 0.01 µg/m³ and has 3 dedicated GMP production suites for clinical and commercial operations

Our collaboration with Yapan-Bio's Indian facility, delivering complete solutions encompassing Process Development and Optimization, Process Characterization, Scale-up, Technology Transfer, and GMP Manufacturing for Large molecule programs

At our Turbhe facility in India, we excel in solution and solid-phase synthesis of peptide API development and manufacturing. Our proficiency in freeze-drying extends to peptides of different complexities. Our portfolio includes commercially successful products in the generic realm

Operating in Mahad, India, our cGMP facility produces a diverse range: oral solids, liquid drug products, human and animal nutrition premixes, vitamins in bulk, sachets, and spray-dried vitamin powders.